Login / Signup
Koji Morita
Scopus Author ID
ORCID
Publication Activity (10 Years)
Years Active: 2018-2023
Publications (10 Years): 7
Top Topics
Amino Acid
Circulating Tumor
Allergic Rhinitis
Immune Response
Top Venues
Bioconjugate chemistry
Molecular pharmaceutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hitomi Irie
,
Koji Morita
,
Miyu Matsuda
,
Makoto Koizumi
,
Shinichi Mochizuki
Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2K b and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.
Bioconjugate chemistry
34 (2) (2023)
Hitomi Irie
,
Koji Morita
,
Miyu Matsuda
,
Makoto Koizumi
,
Shinichi Mochizuki
Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2K b and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.
Bioconjugate chemistry
(2023)
Hitomi Irie
,
Koji Morita
,
Miyu Matsuda
,
Makoto Koizumi
,
Shinichi Mochizuki
Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2K b and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.
Bioconjugate chemistry
34 (2) (2023)
Hitomi Irie
,
Koji Morita
,
Miyu Matsuda
,
Makoto Koizumi
,
Shinichi Mochizuki
Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2K b and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.
Bioconjugate chemistry
34 (2) (2023)
Hitomi Irie
,
Koji Morita
,
Miyu Matsuda
,
Makoto Koizumi
,
Shinichi Mochizuki
Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2K b and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.
Bioconjugate chemistry
34 (2) (2023)
Hitomi Irie
,
Koji Morita
,
Makoto Koizumi
,
Shinichi Mochizuki
Immune Responses and Antitumor Effect through Delivering to Antigen Presenting Cells by Optimized Conjugates Consisting of CpG-DNA and Antigenic Peptide.
Bioconjugate chemistry
31 (11) (2020)
Takako Niwa
,
Yuji Kasuya
,
Yukie Suzuki
,
Kimihisa Ichikawa
,
Hiroko Yoshida
,
Akiko Kurimoto
,
Kento Tanaka
,
Koji Morita
Novel Immunoliposome Technology for Enhancing the Activity of the Agonistic Antibody against the Tumor Necrosis Factor Receptor Superfamily.
Molecular pharmaceutics
15 (9) (2018)